Literature DB >> 18475725

Nitric oxide modulates interleukin-2-induced proliferation in CTLL-2 cells.

J Padrón1, L Glaría, O Martinez, M Torres, E Lopez, R Delgado, L Caveda, A Rojas.   

Abstract

The role of the L-arginine-nitric oxide metabolic pathway was explored for interleukin-2-induced proliferation in the cytotoxic T lymphocyte clone CTLL-2. Specific inhibition of nitric oxide synthase significantly diminished, in a concentration-dependent manner, (3)H-thymidine uptake of CTLL-2 cells in response to different concentrations of interleukin 2. Withdrawal of L-arginine from culture medium resulted as potent as the higher inhibition obtained when blocking nitric oxide synthase with L-arginine analogues. Furthermore, intermedial concentrations of Larginine and exogenous nitric oxide donors were found for achieving optimal IL2-induced proliferation of CTLL-2. These findings prompted us to suggest that intra- and/or inter-cellular nitric oxide signalling may contribute to the modulation of the IL2 mitogenic effect upon cytotoxic T lymphocytes.

Entities:  

Year:  1996        PMID: 18475725      PMCID: PMC2365802          DOI: 10.1155/S0962935196000464

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  14 in total

1.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Kinetic characteristics of nitric oxide synthase from rat brain.

Authors:  R G Knowles; M Palacios; R M Palmer; S Moncada
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

3.  Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein.

Authors:  D J Stuehr; H J Cho; N S Kwon; M F Weise; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

4.  Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline.

Authors:  A M Leone; R M Palmer; R G Knowles; P L Francis; D S Ashton; S Moncada
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

5.  Cyclic GMP metabolism in macrophages. I. Regulation of cyclic GMP levels by calcium and stimulation of cyclic GMP synthesis by NO-generating agents.

Authors:  Y Bromberg; E Pick
Journal:  Cell Immunol       Date:  1980-06       Impact factor: 4.868

6.  Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.

Authors:  R G Knowles; M Palacios; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 7.  Harnessing T-lymphocytes for human cancer immunotherapy.

Authors:  Y Hirshaut; S F Slovin
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

8.  Enhancement of interleukin-2 immunotherapy with L-arginine.

Authors:  M D Lieberman; K Nishioka; H P Redmond; J M Daly
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

9.  Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.

Authors:  J B Hibbs; C Westenfelder; R Taintor; Z Vavrin; C Kablitz; R L Baranowski; J H Ward; R L Menlove; M P McMurry; J P Kushner
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.

Authors:  W H West; K W Tauer; J R Yannelli; G D Marshall; D W Orr; G B Thurman; R K Oldham
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.